Number of the records: 1  

RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer

  1. TitleRASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer
    Author Šebová Katarína SAVEXONK - Ústav experimentálnej onkológie SAV
    Co-authors Zmetáková Iveta 1979- SAVEXONK - Ústav experimentálnej onkológie SAV

    Bella Vladimír

    Horváthová Kajabová Viera 1985- SAVEXONK - Ústav experimentálnej onkológie SAV    ORCID

    Krivulčík Tomáš 1982- SAVEXONK - Ústav experimentálnej onkológie SAV

    Tomka Miroslav 1974- SAVEXONK - Ústav experimentálnej onkológie SAV

    Galbavy S.

    Fridrichová Ivana 1958 SAVEXONK - Ústav experimentálnej onkológie SAV    SCOPUS    RID    ORCID

    Co-authors Kajo Karol Stankovičová Iveta Lasabová Zora
    Source document Cancer Biomarkers. Vol. 10, no. 1 (2012), p. 13-26
    Languageeng - English
    CountryNL - Netherlands
    Document kindrozpis článkov z periodík (rbx)
    CitationsABUDUKADEER, Abida - BAKRY, Rania - GOEBEL, Georg - MUTZ-DEHBALAIE, Irene - WIDSCHWENDTER, Andreas - BONN, Günther K. - FIEGL, Heidi. Clinical relevance of CDH1 and CDH13 DNA-methylation in serum of cervical cancer patients. In International Journal of Molecular Sciences. ISSN 16616596, 2012-01-01, 13, 7, pp. 8353-8363.
    KONDRATOV, Aleksandr G. - KVASHA, Sergiy M. - STOLIAR, Liubov A. - ROMANENKO, Alina M. - ZGONNYK, Yury M. - GORDIYUK, Vasily V. - KASHUBA, Elena V. - RYNDITCH, Alla V. - ZABAROVSKY, Eugene R. - KASHUBA, Vladimir I. Alterations of the WNT7A Gene in Clear Cell Renal Cell Carcinomas. In PLoS ONE, 2012-10-08, 7, 10, pp.
    WANG, Zeng Yan - LI, Jian Guo. Research advance on RASSF1A gene and breast cancer. In Chinese Journal of Cancer Prevention and Treatment. ISSN 16735269, 2012-11-24, 19, 23, pp. 1836-1840.
    NANDEDKAR, Tarala D. Biomarkers for cancers in women: Present status and future perspectives. In Current Women's Health Reviews. ISSN 15734048, 2012-12-01, 8, 4, pp. 297-311.
    CONNOLLY, Roisin - STEARNS, Vered. Epigenetics as a therapeutic target in breast cancer. In Journal of Mammary Gland Biology and Neoplasia. ISSN 10833021, 2012-12-01, 17, 3-4, pp. 191-204.
    SHERBET, Gajanan V. Therapeutic Strategies in Cancer Biology and Pathology. In Therapeutic Strategies in Cancer Biology and Pathology, 2013-07-01, pp. 1-288.
    HUANG, Yi Teng - LI, Fei Fei - KE, Chen - LI, Zhou - LI, Zong Tai - ZOU, Xiao Fang - ZHENG, Xiao Xuan - CHEN, Yu Ping - ZHANG, Hao. PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: Indication for personalized therapy. In Journal of Translational Medicine, 2013-10-03, 11, 1, pp.
    ROMERO-PÉREZ, Laura - LÓPEZ-GARCÍA, M. Ángeles - DÍAZ-MARTÍN, Juan - BISCUOLA, Michele - CASTILLA, M. Ángeles - TAFE, Laura J. - GARG, Karuna - OLIVA, Esther - MATIAS-GUIU, Xavier - SOSLOW, Robert A. - PALACIOS, José. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma. In Modern Pathology. ISSN 08933952, 2013-11-01, 26, 11, pp. 1514-1524.
    KANG, Seongeun - KIM, Byungtak - PARK, Sung Bin - JEONG, Gookjoo - KANG, Han Sung - LIU, Ran - KIM, Sun Jung. Stage-specific methylome screen identifies that NEFL is downregulated by promoter hypermethylation in breast cancer. In International Journal of Oncology. ISSN 10196439, 2013-11-01, 43, 5, pp. 1659-1665.
    KOUREA, Helen P. - ZOLOTA, Vassiliki - SCOPA, Chrisoula D. Targeted pathways in breast cancer: Molecular and protein markers guiding therapeutic decisions. In Current Molecular Pharmacology. ISSN 18744672, 2014-01-01, 7, 1, pp. 4-21.
    GU, Xi - XUE, Jin Qi - ZHU, Xi - YE, Ming Shi - ZHANG, Wen Hai. Aberrant promoter methylation of the CHD1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis. In Tumor Biology. ISSN 10104283, 2014-01-01, 35, 9, pp. 9395-9404.
    BEHNKE, Martha K. - REIMERS, Mark - FISHER, Robert A. Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: Transplant implications. In Annals of Hepatology. ISSN 16652681, 2014-01-01, 13, 1, pp. 45-53.
    YAYKASLI, Kursat Oguz - KAYA, Ertugrul - YAYKASLI, Emine. Epigenomics of breast cancer. In Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy, 2014-04-01, pp. 105-126.
    KIM, Byungtak - KANG, Seongeun - JEONG, Gookjoo - PARK, Sung Bin - KIM, Sun Jung. Identification and comparison of aberrant key regulatory networks in breast, colon, liver, lung, and stomach cancers through methylome database analysis. In PLoS ONE, 2014-05-19, 9, 5, pp.
    BETHGE, Nicole - HONNE, Hilde - ANDRESEN, Kim - HILDEN, Vera - TRØEN, Gunhild - LIESTØL, Knut - HOLTE, Harald - DELABIE, Jan - LIND, Guro E. - SMELAND, Erlend B. A gene panel, including LRP12, is frequently hypermethylated in major types of B-cell lymphoma. In PLoS ONE, 2014-09-16, 9, 9, pp.
    VERMA, Mukesh. The role of epigenomics in the study of cancer biomarkers and in the development of diagnostic tools. In Advances in Experimental Medicine and Biology. ISSN 00652598, 2015-01-01, 867, pp. 59-80.
    KANG, Seongeun - KIM, Byungtak - KANG, Han Sung - JEONG, Gookjoo - BAE, Hansol - LEE, Hyunkyung - LEE, Seungyeon - KIM, Sun Jung. SCTR regulates cell cycle-related genes toward anti-proliferation in normal breast cells while having pro-proliferation activity in breast cancer cells. In International Journal of Oncology. ISSN 10196439, 2015-01-01, 47, 5, pp. 1923-1931.
    PEREZ-JANICES, Noemi - BLANCO-LUQUIN, Idoia - TORREA, Natalia - LIECHTENSTEIN, Therese - ESCORS, David - CORDOBA, Alicia - VICENTE-GARCIA, Francisco - JAUREGUI, Isabel - DE LA CRUZ, Susana - ILLARRAMENDI, José Juan - COCA, Valle - BERDASCO, Maria - KOCHAN, Grazyna - IBAÑEZ, Berta - LERA, José Miguel - GUERRERO-SETAS, David. Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis. In Oncotarget, 2015-01-01, 6, 27, pp. 23944-23958.
    XU, Ben - ZHANG, Lian - LUO, Cheng - QI, Yan - CUI, Yun - YING, Jian Ming - ZHANG, Qian - JIN, Jie. Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma. In International Journal of Molecular Sciences. ISSN 16616596, 2015-01-05, 16, 1, pp. 1051-1065.
    MOELANS, Cathy B. - VLUG, Eva J. - ERCAN, Cigdem - BULT, Peter - BUERGER, Horst - CSERNI, Gabor - VAN DIEST, Paul J. - DERKSEN, Patrick W B. Methylation biomarkers for pleomorphic lobular breast cancer a short report. In Cellular Oncology. ISSN 22113428, 2015-10-01, 38, 5, pp. 397-405.
    ASIAF, Asia - AHMAD, Shiekh Tanveer - AZIZ, Sheikh Aejaz - MALIK, Ajaz Ahmad - RASOOL, Zubaida - MASOOD, Akbar - ZARGAR, Mohammad Afzal. Loss of Expression and Aberrant Methylation of the CDH1 (E-cadherin) Gene in Breast Cancer Patients from Kashmir. In ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. ISSN 1513-7368, 2014, vol. 15, no. 15, pp. 6397.
    ARISTIZABAL-PACHON, A.F. - SATIE-TAKAHASHI, C. Effect of genetics, epigenetics and variations in the transcriptional expression of cadherin-E in breast cancer susceptibility. In BIOMEDICA. ISSN 0120-4157, DEC 2016, vol. 36, no. 4, p. 593-602.
    HOLUBEKOVA, V. - MENDELOVA, A. - GRENDAR, M. - MERSAKOVA, S. - KAPUSTOVA, I. - JASEK, K. - VANOCHOVA, A. - DANKO, J. - LASABOVA, Z. Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimens. In ONCOLOGY LETTERS. ISSN 1792-1074, OCT 2016, vol. 12, no. 4, p. 2613-2621.
    MARTIN-SANCHEZ, E. - PERNAUT-LEZA, E. - MENDAZA, S. - CORDOBA, A. - VICENTE-GARCIA, F. - MONREAL-SANTESTEBAN, I. - VIZCAINO, J.P. - DE CERIO, M.J.D. - PEREZ-JANICES, N. - BLANCO-LUQUIN, I. - ESCORS, D. - ULAZIA-GARMENDIA, A. - GUERRERO-SETAS, D. Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA. In VIRCHOWS ARCHIV. ISSN 0945-6317, JUL 2016, vol. 469, no. 1, p. 51-59.
    LIU, J. - SUN, X. - QIN, S.D. - WANG, H.Z. - DU, N. - LI, Y.B. - PANG, Y.M. - WANG, C.C. - XU, C.W. - REN, H. CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer. In ONCOLOGY LETTERS. ISSN 1792-1074, APR 2016, vol. 11, no. 4, p. 2635-2643.
    HUANG, Y.Q. - GUAN, H. - LIU, C.H. - LIU, D.C. - XU, B. - JIANG, L. - LIN, Z.X. - CHEN, M. Association between RASSF1A promoter methylation and renal cell cancer susceptibility: a meta-analysis. In GENETICS AND MOLECULAR RESEARCH. ISSN 1676-5680, 2016, vol. 15, no. 2.
    EBEID, S.A. - ABD EL MONEIM, N.A. - HEWALA, T.I. - HEMIDA, M.A. - SHEHATA, G. - EL-TAHER, N. Assessment of Hypermethylation of RASSF1A and Protocadherin-10 Tumor Suppressor Genes in Breast Cancer Females: A Six-Year Disease-Free Survival Case-Control Study. In MIDDLE EAST JOURNAL OF CANCER. ISSN 2008-6709, JAN 2016, vol. 7, no. 1, p. 9-20.
    DEB, Siddhartha - GORRINGE, Kylie L. - PANG, Jia-Min B. - BYRNE, David J. - TAKANO, Elena A. - DOBROVIC, Alexander - FOX, Stephen B. BRCA2 carriers with male breast cancer show elevated tumour methylation. In BMC CANCER. ISSN 1471-2407, 2017, vol. 17, no., pp.
    BAE, Hansol - KIM, Byungtak - LEE, Hyunkyung - LEE, Seungyeon - KANG, Han-Sung - KIM, Sun Jung. Epigenetically regulated Fibronectin leucine rich transmembrane protein 2 (FLRT2) shows tumor suppressor activity in breast cancer cells. In SCIENTIFIC REPORTS. ISSN 2045-2322, 2017, vol. 7, no., pp.
    WANG, Yun-Hui - YIN, Yan-Wei - ZHOU, Han - CAO, Yuan-Dong. miR-639 is associated with advanced cancer stages and promotes proliferation and migration of nasopharyngeal carcinoma. In ONCOLOGY LETTERS. ISSN 1792-1074, 2018, vol. 16, no. 6, pp. 6903-6909.
    CONNOLLY, Roisin M. - FACKLER, Mary Jo - ZHANG, Zhe - ZHOU, Xian C. - GOETZ, Matthew P. - BOUGHEY, Judy C. - WALSH, Bridget - CARPENTER, John T. - STORNIOLO, Anna Maria - WATKINS, Stanley P. - GABRIELSON, Edward W. - STEARNS, Vered - SUKUMAR, Saraswati. Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008. In BREAST CANCER RESEARCH AND TREATMENT. ISSN 0167-6806, 2018, vol. 167, no. 1, pp. 107-116.
    KRISHNAMURTHY, Kritika - MISHRA, T. K. - SAXENA, Alpana - DAGA, M. K. - KHURANA, Nita - MASROOR, Mirza - JAMATIA, Elvia. Evaluating NISCH and CDH1 Promoter Hypermethylation in Nonsmokers, Cancer Free Smokers and Lung Cancer Patients: A Case Control Study. In INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY. ISSN 0970-1915, 2019, vol. 34, no. 4, pp. 458-464.
    CategoryADMA - Scientific papers in foreign impacted journals registered in Web of Sciences or Scopus
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2012
    Registered inWOS
    Registered inSCOPUS
    DOI 10.3233/CBM-2012-0230
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    N
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201220111.078Q40.439Q2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.